ArticleThe journal of headache and pain2023

One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study.

M Lanteri-Minet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.